Patients Caring for rare: Celebrating Rare Disease Day 2023 Rare Disease Day is observed annually on what is considered the rarest day of the year.
R&D JP Morgan 2023 - Stefan Weber and Ravi Anand pharmaphorum sits down with Stefan Weber and Ravi Anand of neurology-focused biotech Newron.
R&D JP Morgan 2023 – Claudia Ulbrich Last month, pharmaphorum sat down with Claudia Ulbrich, CEO of Germany-based Cardior.
Digital Health Innovators – Ardy Arianpour In this episode of Health Innovators, Paul Tunnah, Healthware’s chief content officer, sits down with Ardy Arianpour, CEO & co-founder of SEQSTER.
Digital Solving problems in pathology data, with Nathan Buchbinder Jonah Comstock chats with Nathan Buchbinder, co-founder and chief product officer at Proscia.
Digital JP Morgan 2023 – Robin Roberts Robin Roberts, COO and co-founder of the Novartis Biome, was on site at JP Morgan last month in San Francisco, but we weren’t able to pin him down for an interview.
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
